X0306 4 2020-11-02 0001673772 RAPT Therapeutics, Inc. RAPT 0001635616 Brockstedt Dirk G. C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Scientific Officer Common Stock 2020-11-02 4 S false 1910 28.06 D 10256 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.19 to $29.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Includes 1,910 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on October 30, 2020. /s/ Karen C. Lam, Attorney-in-Fact for Dirk Brockstedt 2020-11-03